Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Rainy Day Thoughts
The use case for mRna Vaccines has failed miserably.
Prior to covid, zero mRna-based products were approved by the FDA; meanwhile, more than 100 Monoclonal Antibody-based products received approval for various diseases due to their efficacy and safety profile.
After nearly 3 years of relentless government propaganda to convince us to "take the shots", the term "mRna" now conjures up words and phrases for the average person such as:
"side effects" "causes death" "causes AIDS" "hide DATA 75 years" "doesn’t prevent transmission or spread" "unknown dangers" "untested" "Bill Gates" "Fauci" "Stephane Bancel" "Bourla" "pre-meditated murder" "paper thin liability protections" "pure evil" "propaganda" "poison" "government experiment gone bad" etc.
Recently, co-builder of the Wuhan Institute of Virology and Moderna CEO Stephane Bancel conceded 30 Million + doses of mRna covid vaccines were thrown in the garbage due to lack of demand.
Still, Fauci and others preposterously continue to push boosters while fading into the twilight. This time, based on results in 8 mice. Even a 3 year old child understands such bullsh*t.
Samsung Biologics didn't become a $45 Billion Dollar company under the stewardship of CEO John Rim by producing products nobody wants.
Now that demand for mRna Vaccines is virtually zero, its time for Big League CDMOs like Samsung to swiftly pivot to producing safe and effective Monoclonal Antibody cures. Sustainable growth (business & humanitarian growth) will be achieved with Monoclonal Antibodies.
About a year ago, Samsung Biologics CEO Rim stated he looks forward to bring Enzolytics "life saving" products to patients. The people of the world look forward to this day.
Mindful that Fauci himself attempted to steal the patents for Enzolytics Monoclonal Antibodies in the past, its important to remember that our medicine supply is sacred and politics should not influence regulatory approvals.
RIP and Peace & Blessings to all impacted by the release of covid bioweapon and subsequent mRna based vaccines.
Monoclonal Antibody cures exist; get the cures to the people in need, amigo.
We're early and don't let anyone tell you otherwise. For comparison purposes:
https://twitter.com/UncleBillyMoney/status/1418367831901618180?s=20
Thanks MAGA Patriot for all of your great posts.
INTEL
Thank you for all of your great posts. This is my 1 iHub post of the day.
$ENZC will Get Back to Where it Once Belonged
https://twitter.com/UncleBillyMoney/status/1390336441360822272?s=19
If anyone can navigate the proposed updated rules, it is Charles Cotropia. 40+ years experience as Top Patent Attorney. Partner at one of the best law firms in the world.
Perhaps one of the reasons $ENZC has been radio silent is that he has been heavily involved in the discussions.
I can see him turning this to ENZC's advantage to expedite production and distribution of our mabs and use it as a vehicle to do the same with the numerous products we have in the pipeline.
Yeah I can see them identifying another 10 conserved immutable sites on an infectious disease that may kill you and your loved ones someday. Add a dime.
This is Brilliant, thank you!
Many thanks. The site looks great.
Growing up, I always heard they (the government) had a cure but it was simply too difficult to scale up. Too expensive for everyone to get it. That's for a lot of diseases from what I've always understood.
Did people grow up thinking differently? Magic Johnson was the example given. Also heard stories of experimental treatments going to Top Level people. All the top level people took monoclonal antibodies (for coronavirus after they contracted it) - that's on both sides of the aisle. That indicates mabs are best bet. These guys have been around since '89.
I've been hearing that story since I was 5. So when I see that Los Alamos, Harvard, Duke, USF, Cal, Vienna, Dr. Fauci etc. all validated this biotechnology for decades, then why would #CLONE3 not be the cure? 95-98% effective sounds like a cure to me. We need to help them get funding.
"Its expensive" has always been the reason given for not advancing the cure. Now we have coronavirus. We can't do that again. We need to push forward on all fronts to get a cure.
Who knew who Dr. Fauci even was prior to Coronavirus? I never even heard of a monoclonal antibody. It turns out there is a correlation between the 2 diseases. We don't have a cure for either yet, officially. It is our First Amendment right to express the opinion that we want cures, you have the right to express your opinion too. Peaceful, no violence. We're all Americans.
Great Board, Law. Can you re-post that CBD link with your business? Thank you.
That's awesome. Sounds nice.
Great call. Love to see Elvis and the Godfather working together. God Bless.
Great Point Hamptonite. Hope the Weather is nice out there.
How long does it take an Oak tree to become an Oak tree?
The branches of $ENZC are only now just beginning to provide shade and comfort for those who choose to see what is happening.
You can go sit somewhere else. But this tree will be big enough for everyone to enjoy.
Many lives will be saved.
Billions of dollars will be made.
Why do 400 children die everyday from HIV when we have the cure?
$30.5B Market HIV Meds (Currently Toxic ARVs)
Navigant estimates $17.33B #CLONE3 Sales in 1st 10 yrs
There's no "cure" yet
At least that's what they tell the public
US Validated #CLONE3 @LosAlamosNatLab + 5 int'l labs
Why do 400 kids die a day?
#mAbsSaveLives #AI
VERY INTERESTING THAT THE "PROTECTING THE BIOECONOMY" 'conference' WAS HELD AT THE BUSH SCHOOL ON THE SAME EXACT DAY $ENZC ARRIVED WITH CLONE 3.
https://twitter.com/UncleBillyMoney/status/1346820432587075584?s=20
https://calendar.tamu.edu/tamu/view/event/event_id/200142
“We live in an era of tremendous global change. Policy makers will confront unfamiliar challenges, new opportunities, and difficult choices in the years ahead. I look forward to the Scowcroft Institute supporting policy-relevant research that will contribute to our understanding of these changes, illuminating their implications for our national interest, and fostering lively exchanges about how the United States can help shape a world that best serves our interests and reflects our values.”
? ? ?
Lt. Gen. Brent Scowcroft, USAF (Ret.)
https://bush.tamu.edu/scowcroft/
Just some important people protecting their interests? Or are some actually trying to get the best cures to the people?
Why do 400 children die everyday from HIV when we have the cure?
The company also makes vaccines, as a matter of fact. See #2 directly from BioClonetics own website.
It is highly likely that they signed NDAs with The Bravo Consortium (that is the group they applied to CEPI with, which is why we haven't heard specific details about it in the PR YET). Will be a massive catalyst.
If you were a scientist, wouldn't your "job" be in a lab somewhere? Not "educating" us common folk on the iHub board?
By the way, Mensa asked me to join but I turned them down. Enjoy.
"Biologics, specifically, fully human neutralizing monoclonal antibodies directed against infectious disease, are considered the new frontier in biotechnology.
In the past, the initial starting products were “humanized” rat and mouse mAbs being created for therapeutic use. "Humanized” immunoglobulins are the major immunotherapeutics that are prevalent today. What sets BioClonetics' antibody technology apart from everyone else’s? Our organization has the capacity to clone the human or animal immune system cells. With BioClonetics' proprietary methodologies, stable parent hybridomas cell lines can be created that produce fully human (or animal) antibodies.
BioClonetics specializes in creation of human neutralizing monoclonal antibodies, not "humanized" mouse or rat counterparts, as are the majority of mAb therapeutics in pharmaceutical use today. BioClonetics’ technological methodologies have developed an effective, strong and robust portfolio of biologics that have pharmaceutical application with significant benefits to patients or animals in the global marketplace. From an identified and created parent hybridoma cell line, four distinct and effective products can be produced: (1) fully human neutralizing monoclonal antibody—directed against any pathogen based disease entity—through use in passive immunotherapy; (2) an effective humoral active vaccine that is safe and effective; (3) an oral mini-antibody peptide based medication with an efficacy that is equivalent to the immunologic capacity of the monoclonal antibody produced by parent hybridoma cell; and (4) an entry-fusion inhibitor that is immunologic in character and scope. The applications are broad, effective and beneficial for immunotherapeutic use.
The methodologies and processes for creating immortalized cells that stably produce human monoclonal antibodies is a company proprietary trade secret. BioClonetics is amenable to discussing licensing the innovational technique of cloning the immune system of any species in the animal kingdom.
The Bravo Consortium. Tick Tock.
Be a good little doggy and read it. Then search the companies they applied with. Still 11 month old news? Tick tock
Just re-posting what the company posted back in February and putting some context around it. All publicly available information.
Is Charlie Sheen available for the "Winning" Super Bowl commercial?
Agreed. Navigant estimated $17.33 Billion in Clone 3 sales in first 10 years in limited territories for HIV only.
Add more territories (Eastern Europe, Asia, Africa, WORLD)
Add more products, which they are clearly doing based on information in the PRs and website ("expanding product pipeline" and adding patents for diseases with multi billion dollar markets, etc.)
Add wholly owned subsidiaries to license such products as they're already doing. Virogentics and Biogenysis indicate patent licensing model will come naturally for them and there's a lot more being done in the labs that we don't know about. No one predicted the MS Patent. Nice move.
Add seasoned team of pros who have been there and done that at every level. Dr. Moss knows how to get a product to market and navigate government funding apparatuses established by DARPA, NIH, NSF etc. Check the resumes. Its not hard for them.
They're building a New Big Pharma. For the People. No more toxic pharmaceuticals. Society will benefit greatly.
Current market cap is ludicrously low. Excited for January.
Certain forces want to knock the little guy out of position. No. Holding and adding.
The bioclonetics website mentioned their platform biotech can produce safe and effective vaccine along w 3 others
BioClonetics Proprietary mAb Methodologies & Immunotherapeutic Technologies Platform for Therapeutics
Biologics, specifically, fully human neutralizing monoclonal antibodies directed against infectious disease, are considered the new frontier in biotechnology. In the past, the initial starting products were “humanized” rat and mouse mAbs being created for therapeutic use.
"Humanized” immunoglobulins are the major immunotherapeutics that are prevalent today. What sets BioClonetics' antibody technology apart from everyone else’s? Our organization has the capacity to clone the human or animal immune system cells. With BioClonetics' proprietary methodologies, stable parent hybridomas cell lines can be created that produce fully human (or animal) antibodies.
BioClonetics specializes in creation of human neutralizing monoclonal antibodies, not "humanized" mouse or rat counterparts, as are the majority of mAb therapeutics in pharmaceutical use today. BioClonetics’ technological methodologies have developed an effective, strong and robust portfolio of biologics that have pharmaceutical application with significant benefits to patients or animals in the global marketplace. From an identified and created parent hybridoma cell line, four distinct and effective products can be produced: (1) fully human neutralizing monoclonal antibody—directed against any pathogen based disease entity—through use in passive immunotherapy; (2) an effective humoral active vaccine that is safe and effective; (3) an oral mini-antibody peptide based medication with an efficacy that is equivalent to the immunologic capacity of the monoclonal antibody produced by parent hybridoma cell; and (4) an entry-fusion inhibitor that is immunologic in character and scope. The applications are broad, effective and beneficial for immunotherapeutic use.
The methodologies and processes for creating immortalized cells that stably produce human monoclonal antibodies is a company proprietary trade secret. BioClonetics is amenable to discussing licensing the innovational technique of cloning the immune system of any species in the animal kingdom
Makes no sense. I'm sure Dr. F can clear it up. Its ok for us to re-examine the system that landed us in this situation. Most important thing is getting medicines that work to the people.
Like you said, the ones that show great promise and produce results should never be delayed. Is that what Operation Warp Speed is all about?
Either way, ENZC is funded and moving forward. They confirmed in PR.
Los Alamos Lab confirmed Clone 3 works in 2010. Since then, 5 international labs also validated. That was many years ago. I think they've been making progress since then to get to market (navigating swamp) and now that they also have their Target on coronavirus, they are going to expand more rapidly.
Just look at the big moves to big labs in France and Italy. 2 hot spots with people on the ground READY TO MOBILIZE AND MOVE THE REAL SOLUTION TO MARKET. They've been ahead of us on the wave of coronavirus since it took a 1 way flight from Wuhan all those months ago.
ENZC is going to help the world.
That's it. Right there. Plain and simple. The best medicine should be available for everyone to choose. Let's get the economy going again and find more real things that work for the people on every level.
Economy needs to do well to improve our schools and give kids a chance. Masks in the classroom? 99% survival rate but too many stories of weeks long suffering that can be mitigated by MONOCLONAL ANTIBODIES. They work so lets get the 1989 #mabs Pioneers everything they need to succeed.
The people pay the taxes. The agencies must act for the people. Allocate funds. The future is bright.
Then we can give the kids everything they need to succeed. Better economy solves problems. Not create them.
Thank you for sharing
Defense Production Act time for the Improved Wave of new therapeutics that are being developed based on real life science and real life updates to the coronavirus mutation. ENZC is at Texas A&M for a reason. God willing.
Great post as always. Thank you for sharing this. 2021 looks bright.
Agreed! Thanks for the reminder. Made me remember those hundreds of patents CEO Cotropia secured for the World's Top Scientists. All public record! Amazing.
NEW BIG PHARMA FORMING RIGHT IN FRONT OF THE WORLD!!!
$ENZC CEO mentioned an "expanding pipeline of products for treating serious illnesses" in the PR regarding the MS Patent
CEO helped secure 200+ Patents for World's Top Scientists. Including #CRISPR Patents
Has inside track on "what's next" in biotechnology & important IP rights https://t.co/cNaRtHsSaO
Exactly! The MS Patent will save lives and expand market cap/PPS as well.
1 filing away from getting current and majority shareholder CEO Cotropia will provide great, detailed PRs as he's been doing for the past few months.
The best part about ENZC'S PRs is they tell you exactly what they're doing, what they're going to do, and then they do it.
I think Updates from Texas A&M, San Raffaele (Milan), Strasbourg France and Bulgarian labs will be monumental.
Thats a ton of international labs to be at to work on a global pandemic. Not there just to research
$ENZC
Check out @Guidehouse & @GuidehouseHC https://guidehouse.com/
@Guidehouse acquired Navigant for $1.
1 Billion 2019
Navigant estimated $17.33 Billion in #CLONE3 sales in first 10 years in North America and Western Europe back in 2017.
$ENZC trades under $200M MC
N*VAX G*L*SI move coming
Games over soon . . .
https://t.co/EMGNb8yne1
#2 read board. Been in the #1 or 2 spot for many months. . . Many eyes on this one . . . $ENZC is a multi billion dollar biotech trading for less than $200M market cap. Inches away from getting current.
https://investorshub.advfn.com/boards/most_read.aspx
The WSJ Article was good but missing a lot of key info. Looks like the authors had limited space.
The article does not assert Lilly or Regeneron are using monoclonal antibodies derived from humans. It says they develop mabs that "mimic" the human system (or "take a page" etc.).
Go to Lilly and Regeneron website; it tells you how they make their mabs (spoiler alert: not from humans and they don't prevent virus escape as the virus inevitably mutates the same way ENZC does).
ENZC'S methodology has been outlined in great detail by CEO Cotropia. I'm on the run but can be found easily by anyone who wants to find it.
He even explained why Lilly mabs would fail 2 months ago in a PR and why ENZC methodology based on 30+ years of proven science was better. He was right about Lilly as we all know from recent headlines. Given the huge market (many billions), one can conclude that ENZC is in high demand right now. Looking forward to hearing updates from the company. But anyone who thinks this is only a $200M market cap company is kidding themselves. Should be trading 10x this PPS easily. Enjoy the cheapies if they last.
Yeah, they're definitely working as a team. I have a few ideas about what they're up to.
Bottom Line: Stop Sign coming down any moment this week with the June quarterlies being filed on the 23rd. This stock cannot be held down forever.
Market cap under 200M with all of the info available? No one who did DD is buying this crap from the MMs. If you sold or set a Stop Loss in sitting duck territory and got hit, then that's on them. glta
A lot of buzz on $ENZC over this holiday weekend. Hope everyone enjoyed Christmas, Hannukkah, and whatever you like to celebrate.
Here's the Stocktwits message. I'm loading more Monday. Ground Floor.
New Big Pharma being formed right in front of us!
http://stocktwits.com/UncleBillyMoney/message/267489183
Great find. Gilead would be awesome partners. Posted this on Stocktwits earlier:
$ENZC
#CLONE3 = Disruptor Biotech
2017: Navigant estimate $17.33 Billion from #CLONE3 sales
How much now?
Tapped to work on #coronavirus cure at Global Labs
Added MS Patent
A+ Board (Dr Moss worked w Jonas Salk)
Seismic BioPharma Market Shift on Horizon
#mAbsSaveLives #AI https://t.co/51iZrRSkyG
Agreed! Cheers to Ct808, class act!
Navigant valued BioClonetics at $126M back in 2017. Don't let Market Manipulators convince you the company has somehow lost value since then.
Since then, they've hit milestones with Clone3, got set up at Texas A&M and labs in Bulgaria, France and Italy (along with top international scientists), merged w Enzolytics, and added Nasdaq level advisory board.
They bring on pharma Sherpa Dr. Moss and already have the ball rolling on ITV-1.
They're building a new big pharma.
BioClonetics Proprietary mAb Methodologies & Immunotherapeutic Technologies Platform for Therapeutics
Biologics, specifically, fully human neutralizing monoclonal antibodies directed against infectious disease, are considered the new frontier in biotechnology. In the past, the initial starting products were “humanized” rat and mouse mAbs being created for therapeutic use. "Humanized” immunoglobulins are the major immunotherapeutics that are prevalent today.
What sets BioClonetics' antibody technology apart from everyone else’s?
Our organization has the capacity to clone the human or animal immune system cells. With BioClonetics' proprietary methodologies, stable parent hybridomas cell lines can be created that produce fully human (or animal) antibodies.
BioClonetics specializes in creation of human neutralizing monoclonal antibodies, not "humanized" mouse or rat counterparts, as are the majority of mAb therapeutics in pharmaceutical use today. BioClonetics’ technological methodologies have developed an effective, strong and robust portfolio of biologics that have pharmaceutical application with significant benefits to patients or animals in the global marketplace.
From an identified and created parent hybridoma cell line, four distinct and effective products can be produced:
(1) fully human neutralizing monoclonal antibody—directed against any pathogen based disease entity—through use in passive immunotherapy;
(2) an effective humoral active vaccine that is safe and effective;
(3) an oral mini-antibody peptide based medication with an efficacy that is equivalent to the immunologic capacity of the monoclonal antibody produced by parent hybridoma cell; and
(4) an entry-fusion inhibitor that is immunologic in character and scope. The applications are broad, effective and beneficial for immunotherapeutic use.
The methodologies and processes for creating immortalized cells that stably produce human monoclonal antibodies is a company proprietary trade secret.
BioClonetics is amenable to discussing licensing the innovational technique of cloning the immune system of any species in the animal kingdom[/i].
Sincerest thank you for sharing this information. I believe they are lining this up for a big run. All the best sir!
Great post. Please Sticky this and Timing101 posts
Another great post Timing. Thank you.
ct808, please share any updates from 12/21 if you can.
We all see the amazing upside here.